783 related articles for article (PubMed ID: 20071534)
1. Dysregulation of mTOR signaling in fragile X syndrome.
Sharma A; Hoeffer CA; Takayasu Y; Miyawaki T; McBride SM; Klann E; Zukin RS
J Neurosci; 2010 Jan; 30(2):694-702. PubMed ID: 20071534
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression.
Niere F; Wilkerson JR; Huber KM
J Neurosci; 2012 Apr; 32(17):5924-36. PubMed ID: 22539853
[TBL] [Abstract][Full Text] [Related]
3. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
Nosyreva ED; Huber KM
J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
[TBL] [Abstract][Full Text] [Related]
5. Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.
Iliff AJ; Renoux AJ; Krans A; Usdin K; Sutton MA; Todd PK
Hum Mol Genet; 2013 Mar; 22(6):1180-92. PubMed ID: 23250915
[TBL] [Abstract][Full Text] [Related]
6. Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation.
Ronesi JA; Huber KM
J Neurosci; 2008 Jan; 28(2):543-7. PubMed ID: 18184796
[TBL] [Abstract][Full Text] [Related]
7. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
Ronesi JA; Collins KA; Hays SA; Tsai NP; Guo W; Birnbaum SG; Hu JH; Worley PF; Gibson JR; Huber KM
Nat Neurosci; 2012 Jan; 15(3):431-40, S1. PubMed ID: 22267161
[TBL] [Abstract][Full Text] [Related]
8. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.
Bhattacharya A; Kaphzan H; Alvarez-Dieppa AC; Murphy JP; Pierre P; Klann E
Neuron; 2012 Oct; 76(2):325-37. PubMed ID: 23083736
[TBL] [Abstract][Full Text] [Related]
9. Modulation of dendritic spines and synaptic function by Rac1: a possible link to Fragile X syndrome pathology.
Bongmba OY; Martinez LA; Elhardt ME; Butler K; Tejada-Simon MV
Brain Res; 2011 Jul; 1399():79-95. PubMed ID: 21645877
[TBL] [Abstract][Full Text] [Related]
10. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.
Narayanan U; Nalavadi V; Nakamoto M; Thomas G; Ceman S; Bassell GJ; Warren ST
J Biol Chem; 2008 Jul; 283(27):18478-82. PubMed ID: 18474609
[TBL] [Abstract][Full Text] [Related]
11. Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice.
Sawicka K; Pyronneau A; Chao M; Bennett MV; Zukin RS
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6290-E6297. PubMed ID: 27663742
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.
Muddashetty RS; Kelić S; Gross C; Xu M; Bassell GJ
J Neurosci; 2007 May; 27(20):5338-48. PubMed ID: 17507556
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated NMDA-Receptor Signaling Inhibits Long-Term Depression in a Mouse Model of Fragile X Syndrome.
Toft AK; Lundbye CJ; Banke TG
J Neurosci; 2016 Sep; 36(38):9817-27. PubMed ID: 27656021
[TBL] [Abstract][Full Text] [Related]
14. Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.
Zhang J; Hou L; Klann E; Nelson DL
J Neurophysiol; 2009 May; 101(5):2572-80. PubMed ID: 19244359
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
16. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis.
Auerbach BD; Bear MF
J Neurophysiol; 2010 Aug; 104(2):1047-51. PubMed ID: 20554840
[TBL] [Abstract][Full Text] [Related]
17. Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
Connor SA; Hoeffer CA; Klann E; Nguyen PV
Learn Mem; 2011; 18(4):207-20. PubMed ID: 21430043
[TBL] [Abstract][Full Text] [Related]
18. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
19. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome.
Hoeffer CA; Sanchez E; Hagerman RJ; Mu Y; Nguyen DV; Wong H; Whelan AM; Zukin RS; Klann E; Tassone F
Genes Brain Behav; 2012 Apr; 11(3):332-41. PubMed ID: 22268788
[TBL] [Abstract][Full Text] [Related]
20. c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins.
Schmit TL; Dowell JA; Maes ME; Wilhelm M
J Neurochem; 2013 Dec; 127(6):772-81. PubMed ID: 24047560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
